CellSeed Inc. (TYO:7776)

Market Cap	10.21B -26.0%
Revenue (ttm)	161.00M -19.1%
Net Income	-914.00M
EPS	-53.15
Shares Out	35.56M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	494,600
Average Volume	1,184,950
Open	296.00
Previous Close	295.00
Day's Range	282.00 - 296.00
52-Week Range	231.00 - 742.00
Beta	1.10
RSI	43.11
Earnings Date	Feb 13, 2026

About CellSeed

CellSeed Inc. engages in the cell sheet regenerative medicine business in Japan. It is involved in the commercializing regenerative medicine using cell sheets. The company also offers cell cultureware services, and contract development and manufacturing services; UpCell, a temperature-responsive cell cultureware for cell sheet engineering; RepCell for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides ThermoPlate III, a heating element; cellZscope, an automated cell monitoring systems; and cell sheet suppor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 44
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7776

Financial Performance

In 2021, CellSeed's revenue was 161.00 million, a decrease of -19.10% compared to the previous year's 199.00 million. Losses were -914.00 million, 16.7% more than in 2020.